rs3918011

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000760.4(CSF3R):​c.108C>T​(p.Val36Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00256 in 1,607,150 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 8 hom. )

Consequence

CSF3R
NM_000760.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.669

Publications

6 publications found
Variant links:
Genes affected
CSF3R (HGNC:2439): (colony stimulating factor 3 receptor) The protein encoded by this gene is the receptor for colony stimulating factor 3, a cytokine that controls the production, differentiation, and function of granulocytes. The encoded protein, which is a member of the family of cytokine receptors, may also function in some cell surface adhesion or recognition processes. Alternatively spliced transcript variants have been described. Mutations in this gene are a cause of Kostmann syndrome, also known as severe congenital neutropenia. [provided by RefSeq, Aug 2010]
CSF3R Gene-Disease associations (from GenCC):
  • hereditary neutrophilia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • autosomal recessive severe congenital neutropenia due to CSF3R deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 1-36475630-G-A is Benign according to our data. Variant chr1-36475630-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 434838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.669 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00183 (278/152246) while in subpopulation NFE AF = 0.00324 (220/68006). AF 95% confidence interval is 0.00288. There are 1 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF3RNM_000760.4 linkc.108C>T p.Val36Val synonymous_variant Exon 4 of 17 ENST00000373106.6 NP_000751.1 Q99062-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF3RENST00000373106.6 linkc.108C>T p.Val36Val synonymous_variant Exon 4 of 17 1 NM_000760.4 ENSP00000362198.2 Q99062-1

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
278
AN:
152128
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00323
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00170
AC:
425
AN:
250372
AF XY:
0.00183
show subpopulations
Gnomad AFR exome
AF:
0.000678
Gnomad AMR exome
AF:
0.000666
Gnomad ASJ exome
AF:
0.00251
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00311
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00264
AC:
3844
AN:
1454904
Hom.:
8
Cov.:
31
AF XY:
0.00253
AC XY:
1827
AN XY:
722162
show subpopulations
African (AFR)
AF:
0.000390
AC:
13
AN:
33354
American (AMR)
AF:
0.000605
AC:
27
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.00219
AC:
57
AN:
26042
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39484
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86116
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53338
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5488
European-Non Finnish (NFE)
AF:
0.00328
AC:
3627
AN:
1106454
Other (OTH)
AF:
0.00167
AC:
100
AN:
60018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
207
414
622
829
1036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00183
AC:
278
AN:
152246
Hom.:
1
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41542
American (AMR)
AF:
0.000915
AC:
14
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00324
AC:
220
AN:
68006
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00294
Hom.:
0
Bravo
AF:
0.00186
EpiCase
AF:
0.00365
EpiControl
AF:
0.00285

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CSF3R: BP4, BP7, BS2 -

not specified Benign:1
Feb 24, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive severe congenital neutropenia due to CSF3R deficiency Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CSF3R-related disorder Benign:1
Feb 19, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
6.4
DANN
Benign
0.58
PhyloP100
0.67
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3918011; hg19: chr1-36941231; COSMIC: COSV58968496; COSMIC: COSV58968496; API